Annie Li

Xinyu (Annie) Li advises life sciences and technology companies, investors, and other clients on a wide range of complex corporate and transactional matters. Her transactional practice focuses on strategic licensing, collaboration, alliance, supply, manufacturing, and other commercial agreements that support the research, development, and commercialization of innovative products. Annie regularly advises and plays key role in structuring and negotiating high-value, often cross-border agreements with global pharmaceutical and biotechnology companies and other international counterparties. She also advises on mergers and acquisitions and other strategic transactions in the life sciences sector, as well as the negotiation, structuring, and drafting of commercial agreements in the ordinary course of business.

Annie’s practice also includes representing emerging companies and investors in venture capital and growth equity financings across all stages of the company lifecycle. She has experience advising on cross-border financings and investments. She advises on corporate formation, equity financings, and general governance matters, working closely with founders, management teams, and investors to help execute growth strategies from formation through exit.